|
|
Volumn 18, Issue 1, 2013, Pages 43-54
|
|
Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ILOPERIDONE;
ISOXAZOLE DERIVATIVE;
NEUROLEPTIC AGENT;
PIPERAZINE DERIVATIVE;
PIPERIDINE DERIVATIVE;
THIAZOLE DERIVATIVE;
ZIPRASIDONE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ADMINISTRATION;
DRUG SUBSTITUTION;
FEMALE;
HUMAN;
INDIA;
LONGITUDINAL STUDY;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PSYCHOLOGICAL RATING SCALE;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
TIME;
TREATMENT OUTCOME;
UNITED STATES;
ADOLESCENT;
ADULT;
AGED;
ANTIPSYCHOTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG SUBSTITUTION;
FEMALE;
HUMANS;
INDIA;
ISOXAZOLES;
LONGITUDINAL STUDIES;
MALE;
MIDDLE AGED;
PIPERAZINES;
PIPERIDINES;
PSYCHIATRIC STATUS RATING SCALES;
SCHIZOPHRENIA;
THIAZOLES;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
YOUNG ADULT;
|
|
EID: 84879020098
PISSN: 10928529
EISSN: None
Source Type: None
DOI: 10.1017/S1092852912000764 Document Type: Article |
|
Times cited : (26)
|
|
References (0)
|
